Skip to main content

Table 4 Association of country-specific innovation activities with DALYs in the corresponding countries

From: Disease burden metrics and the innovations of leading pharmaceutical companies: a global and regional comparative study

Country

Correlation coefficient (r)

(European Region)

 Germany

0.649**

 Hungary

0.670**

 United Kingdom

0.563*

(Western Pacific Region)

 China

0.660**

 Japan

0.659**

 South Korea

0.633**

(Region of the Americas)

 Canada

0.641**

 Uruguay

0.603*

 United States

0.647**

(South-East Asia Region)

 Bangladesh

0.169

 Indonesia

0.316

 Myanmar

0.084

(Eastern Mediterranean Region)

 Iran

n/a

 Kuwait

0.430

 Saudi Arabia

0.346

(African Region)

 Rwanda

n/a

 South Africa

0.311

 Uganda

0.394

  1. *p < 0.05
  2. **p < 0.01